Overview
rs4562 is a genetic variant on gene CLDN7.
This variant is located on chromosome 17. The variations at position 7260420 are the genetic letters A/A, G/G, A/G
Since humans have each twice (one from each parent), these letter-variations occur on both chromosomes. People can have the same or different letters on both chromosomes. Every person's individual variation combination is referred to as genotype. For variant rs4562 there are 3 currently known genotypes : A/A, G/G or A/G
Short Overview
Variant Location
rs4562 is located on gene CLDN7 in chromsome 17. Use the genome browser to explore the location of rs4562 and its genetic neighbourhood.
Conditions & Traits
rs4562 affects the following conditions and traits:
There are currently 0 conditions and 0 traits associated with rs4562.
Pathogenicity
rs4562 affects the following conditions:
There are currently 0 conditions associated with rs4562.
Genome Browser
This interactive browser visualizes what no human can see with the naked eye - our DNA. From a down to a specific position on a . The position you are looking at here is the exact location of variant rs on gene CLDN7. Explore more variants and their effects on the body by browsing left and right along the DNA strand.
Did you know genetic variants affect drugs?
Mutations are changes in genes and genetic variations are differences in the DNA among people. Variants are tiny changes in just one piece of the DNA while haplotypes are groups of these changes that usually come together.
Conditions & Traits of rs4562
Current research shows 0 conditions and 0 traits.
Conditions
0Pharmacogenetics
The genetic variant rs4562 impacts how certain medications work in the body. This difference may cause some of us to require different dosage amounts to achieve the desired effects, while others might experience more apparent side-effects. As a result, healthcare providers may need to adjust prescriptions for those individuals with rs4562. Ultimately, understanding our genetic makeup helps improve the overall effectiveness and usability of medications. Tailoring treatments based on genetics ensures a safer, more personalized healthcare experience.
Genotype
Level of evidence
Impacts
Summary
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype A/A have increased Drug Effect to METHYLPHENIDATE.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype A/G have increased Drug Effect to METHYLPHENIDATE.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/G have decreased Drug Effect to METHYLPHENIDATE.
more info
Legend:
Increased
Decreased
No known effect
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype A/A have increased Drug Effect to METHYLPHENIDATE.
Level of evidence
More info
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype A/G have increased Drug Effect to METHYLPHENIDATE.
Level of evidence
More info
Genotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Summary
Individuals with the genotype G/G have decreased Drug Effect to METHYLPHENIDATE.
Level of evidence
More info
Legend:
Increased
Decreased
No known effect